MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: A comparison of primary tumors and distant metastases

Annals of Surgical Oncology

Volumn 21, Issue 3, 2014, Pages 1046-1054

  Heinzelmann, Joana ^a,b   Unrein, André ^b   Wickmann, Ulrike ^b   Baumgart, Sophie ^a,b   Stapf, Marcus ^b   Szendroi, Attila ^c   Grimm, Marc Oliver ^b   Gajda, Mieczyslaw R ^b   Wunderlich, Heiko ^b,d   Junker, Kerstin ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Eisenach St Georg Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CELL; CANCER PROGNOSIS; CELL ADHESION; CELL MIGRATION; COMPARATIVE STUDY; DISTANT METASTASIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY TUMOR; VISCERAL METASTASIS;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84896726090     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3361-3     Document Type: Article

References (30)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-97.
2. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122(1):6-7. doi: 10.1016/j.cell.2005.06.036.
3. Huang ZM, Yang J, Shen XY, et al. MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer. J Dig Dis. 2009;10(3):188-94. doi: 10.1111/j.1751-2980.2009.00384.x.
4. Junker K, Ficarra V, Kwon ED, Leibovich BC, Thompson RH, Oosterwijk E. Potential role of genetic markers in the management of kidney cancer. Eur Urol. 2013;63(2):333-40. doi: 10.1016/j.eururo.2012.09.040.
5. Jung M, Mollenkopf HJ, Grimm C, et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med. 2009;13(9B):3918-28. doi: 10.1111/j.1582-4934.2009.00705.x.
6. Juan D, Alexe G, Antes T, et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology. 2010;75(4):835-41. doi: 10.1016/j.urology. 2009.10.033.
7. Nakada C, Matsuura K, Tsukamoto Y, et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol. 2008;216(4):417-27. doi: 10.1002/path.2437.
8. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol. 2009;35(1):109-14.
9. Youssef YM, White NM, Grigull J, et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol. 2011;59(5)721-30. doi: 10.1016/j.eururo.2011.01.004.
10. Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007;25:387-92. doi: 10.1016/j.urolonc.2007.01.019.
11. Chow TF, Youssef YM, Lianidou E, et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem. 2010;43(1-2):150-8. doi: 10.1016/j.clinbiochem.2009. 07.020.
12. Storkel S, van den Berg E. Morphological classification of renal cancer. World J Urol. 1995;13(3):153-8.
13. Heinzelmann J, Henning B, Sanjmyatav J, et al. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol. 2011;29(3):367-73. doi: 10.1007/s00345-010-0633-4.
14. Saito K, Oku T, Ata N, Miyashiro H, Hattori M, Saiki I. A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors. Biol Pharm Bull. 1997;20(4):345-8.
15. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-66. doi: 10.1038/nrc1997.
16. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-69. doi: 10.1038/nrc1840.
17. Catto JW, Alcaraz A, Bjartell AS, et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011;59(5):671-81. doi: 10.1016/j.eururo.2011.01.044.
18. Williams RD, Elliott AY, Stein N, Fraley EE. In vitro cultivation of human renal cell cancer. II. Characterization of cell lines. In Vitro. 1978;14(9):779-6.
19. Boominathan L. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev. 2010;29(4);613-39. doi: 10.1007/s10555-010-9257-9.
20. Braun J, Hoang-Vu C, Dralle H, Huttelmaier S. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene. 2010;29(29):4237-44. doi: 10.1038/onc.2010.169.
21. Khella H, White N, Faragalla H, et al. Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumor Biol. 2012;33(1):131-40. doi: 10.1007/s13277-011- 0255-5.
22. White NM, Khella HW, Grigull J, et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br J Cancer. 2011;105(11):1741-9. doi: 10.1038/bjc.2011.401.
23. Feng R, Chen X, Yu Y, et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 2010;298(1):50-63. doi: 10.1016/j.canlet. 2010.06.004.
24. Donnem T, Lonvik K, Eklo K, et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer. 2011;117(14):3193-200. doi: 10.1002/cncr.25907.
25. Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451(7175):147-52. doi: 10.1038/nature06487.
26. Wotschofsky Z, Liep J, Meyer HA, et al. Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas. Int J Biol Sci. 2012;8(10):1363-74. doi: 10.7150/ijbs.5106.
27. Wu X, Weng L, Li X, et al. Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis. PLoS ONE. 2012;7(5):e35661. doi: 10.1371/journal.pone.0035661.
28. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682-8. doi: 10.1038/nature06174.
29. Liu Z, Zhu J, Cao H, Ren H, Fang X. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol. 2012;40(5):1553-60. doi: 10.3892/ijo.2012.1342.
30. Lin J, Teo S, Lam DH, Jeyaseelan K, Wang S. MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme. Cell Death Dis. 2012;3:e398. doi: 10.1038/cddis.2012.134.